Form D — BridgeHealth Pharmaceuticals, Inc.
0002162724-26-000001 · filed Nov 5, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Reported offering amount
- $3,500,000
- Reported amount sold
- $3,500,000
- Minimum investment
- $0
- Investors
- 5
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- BridgeHealth Pharmaceuticals, Inc.
- CIK
- 2162724
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 400 TRADECENTER
WOBURN, MA 01801 - Phone
- 781-569-5866
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Neal Muni · Executive OfficerWoburn, MA Find on LinkedIn ↗
-
Indu Muni · Executive OfficerWoburn, MA Find on LinkedIn ↗
-
Howard Ackerman · DirectorWoburn, MA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗